Civica

Leading Health Systems Launch Graphite Health, a New Member-Led Non-Profit Company to Accelerate Digital Transformation of Health Care

Retrieved on: 
Tuesday, October 5, 2021
Graphite, Adoption, Data science, Civica Rx, Aetna, Human, Efficiency, Negotiation, Trust, Solution, Smartphone, Civica, Privacy, Health, Multimedia, Patient, Presbyterian Healthcare Services, MD, Hospital, Board, Senior, CEO, Industry, Knowledge, Intermountain Healthcare, COVID-19, Technology, Service, Contract, Doctor of Philosophy, Digital, SSM Health, Mobile phone, Medicine, Management

"The digital revolution that advanced every industry in the world missed health care," said Dr. Ries Robinson, CEO of Graphite Health and Chief Innovation Advisor at Presbyterian Healthcare Services.

Key Points: 
  • "The digital revolution that advanced every industry in the world missed health care," said Dr. Ries Robinson, CEO of Graphite Health and Chief Innovation Advisor at Presbyterian Healthcare Services.
  • By doing so, Graphite Health will accelerate access to valuable digital tools that can deliver better health care outcomes at a lower cost."
  • Graphite Health anticipates bringing additional health care systems and philanthropies into their coalition in the coming months, as well as partnering with leading technology innovators.
  • Graphite Health is a member-led company intent on transforming digital health care to improve patient outcomes and lower costs.

Central Virginia to fast-track development of advanced pharmaceutical manufacturing with launch of 'cluster accelerator'

Retrieved on: 
Monday, October 4, 2021
CEO, North East of England Process Industry Cluster, Medication, Civica, Workforce, Commerce, Entrepreneurship, Industry, Virginia Commonwealth University, COVID, Virginia State University, City, Growth, Private sector, Knowledge, University, Technology, Commonwealth, Cluster, Organization, Economic development, Ecosystem, Pharmaceutical industry, Renewable energy, Management

RICHMOND, Va., Oct. 4, 2021 /PRNewswire/ --Activation Capital, a leading entrepreneurship and ecosystem development organization, announced the launch of a cluster accelerator to catalyze the growth of advanced pharmaceutical manufacturing and R&D in Central Virginia.

Key Points: 
  • RICHMOND, Va., Oct. 4, 2021 /PRNewswire/ --Activation Capital, a leading entrepreneurship and ecosystem development organization, announced the launch of a cluster accelerator to catalyze the growth of advanced pharmaceutical manufacturing and R&D in Central Virginia.
  • The regional cluster accelerator's goal is to help build a globally competitive pharmaceutical manufacturing and R&D industry in the Central Virginia region.
  • Many organizations will support scale-up in infrastructure, workforce development, and supply chain development.
  • Established in 1993, the Virginia Biotechnology Research Partnership Authority (dba Activation Capital) is a political subdivision of the Commonwealth of Virginia.

CIVICA Selects Vonage for Next Generation Local Authority Communications

Retrieved on: 
Tuesday, April 27, 2021
Technology, Mobile, Wireless, Public policy, Government, Professional services, Audio, Video, Software, Networks, State, Local, Other Professional Services, Articles, Holmdel Township, New Jersey, Vonage, Business, Civica, Digital transformation, Workflow, Vonage, Civica Group, VONAGE, CIVICA GROUP

b"Vonage (Nasdaq: VG), a global leader in cloud communications helping businesses accelerate their digital transformation, has been chosen by Civica , a global leader in software for public services, to lead the digital transformation of local authority communications channels.\nCivica Modern.Gov manages the digital solutions of over 300 local authorities in the UK.

Key Points: 
  • b"Vonage (Nasdaq: VG), a global leader in cloud communications helping businesses accelerate their digital transformation, has been chosen by Civica , a global leader in software for public services, to lead the digital transformation of local authority communications channels.\nCivica Modern.Gov manages the digital solutions of over 300 local authorities in the UK.
  • Traditional methods are no longer effective in meeting the engagement needs of service users.\n\xe2\x80\x9dVonage understands this, and through the Vonage Communications Platform we are empowering organisations like Civica to do what\xe2\x80\x99s next and stay ahead.
  • CCS supports the public sector to achieve maximum commercial value when procuring common goods and services.
  • Vonage's Communications Platform is fully programmable and allows for the integration of Video, Voice, Chat, Messaging and Verification into existing products, workflows and systems.

Civica to Build an Essential Medicines Manufacturing Facility in Virginia

Retrieved on: 
Thursday, January 21, 2021
General Health, Pharmaceutical, Health, Other Health, Natural sciences, Civica Rx, Chemistry, Civica, Essential medicines, Fine chemical, Life sciences, Civica Rx, Phlow

Civica Rx (Civica, Inc.) today announced, along with Virginias Governor Ralph Northam , its plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia, potentially creating more than 180 jobs.

Key Points: 
  • Civica Rx (Civica, Inc.) today announced, along with Virginias Governor Ralph Northam , its plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia, potentially creating more than 180 jobs.
  • This is a dream come true for Civica and our hospital partners as we continue to work together to stabilize the supply of essential medicines for patients across the country, said Martin VanTrieste, President and CEO of Civica.
  • Civica is a key collaborator in the U.S. government-funded partnership with Phlow Corp., Medicines for All Institute at Virginia Commonwealth University and AMPAC Fine Chemicals, which is also located in Petersburg.
  • The company will manufacture precursor chemical ingredients, active pharmaceutical ingredients (API), and finished pharmaceutical products, domestically for essential medicines critical to the Nations healthcare.

Govzilla announces new customer platform and company name change to Redica Systems

Retrieved on: 
Friday, November 20, 2020
Civica

The company will begin operating under the name Redica Systems, effective immediately.

Key Points: 
  • The company will begin operating under the name Redica Systems, effective immediately.
  • Today, Redica Systems is fully focused on achieving its mission of empowering the champions of quality and safety with actionable data intelligence.
  • "Redica Systems has what it takes to reinvent the entire quality & compliance industry," said Martin VanTrieste, CEO of Civica and member of Redica Systems' board of directors.
  • Along with the adoption of a new company name and a new logo, Redica Systems has relaunched its website: www.redica.com .

Essential Medicines Company Civica Rx Turns 2, Marking Numerous Milestones

Retrieved on: 
Wednesday, September 2, 2020
Infectious diseases, Pharmaceutical, Health, Civica, Health, Sedative, Medication, Coronavirus disease, Articles, Natural sciences, Civica Rx

Today, Civica serves over 50 health systems, representing more than 1,200 hospitals and over 30 percent of all hospital beds in the United States.

Key Points: 
  • Today, Civica serves over 50 health systems, representing more than 1,200 hospitals and over 30 percent of all hospital beds in the United States.
  • Eleven Civica medications are being used to help treat COVID-19 patients, including neuromuscular blocking agents, sedatives, pain relievers, and blood thinners.
  • Hikma is proud to partner with Civica in providing essential medicines to hospitals and their patients in this time of national crisis.
  • Since established, the #1 Policy for the Civica team has been Do What Is in the Best Interest of Patients.

Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals

Retrieved on: 
Tuesday, July 7, 2020
Civica Rx, Civica, Industries

PRINCETON, N.J., July 7, 2020 /PRNewswire/ --Sandoz Inc. today announced it has entered into a long-term agreement with Civica Rx (Civica, Inc.) to manufacture and supply critical injectable generic medicines, to help reduce supply shortages and ensure acute care settings can deliver optimal patient care.

Key Points: 
  • PRINCETON, N.J., July 7, 2020 /PRNewswire/ --Sandoz Inc. today announced it has entered into a long-term agreement with Civica Rx (Civica, Inc.) to manufacture and supply critical injectable generic medicines, to help reduce supply shortages and ensure acute care settings can deliver optimal patient care.
  • Under the five-year agreement, Sandoz will supply six injectable medicines widely used at Civica's 1,200 US member hospitals, to help ensure patients have access to high-quality, critical medicines when needed.
  • "Frequent supply shortages of critical generic medicines result in additional pressure for hospitals and their staff and often lead to sub-optimal patient care.
  • "With Sandoz by our side, we will be able to stabilize the supply of more vital medicines used in hospitals daily and in times of crisis," said Martin VanTrieste, President and CEO of Civica Rx.

Civica Rx Partners with Thermo Fisher Scientific to Develop and Manufacture Drugs with a History of Drug Shortages

Retrieved on: 
Thursday, January 16, 2020
Health, Pharmaceutical, Life sciences, Pharmaceutical industry, Health, Articles, Civica Rx, Civica, Food and Drug Administration, Abbreviated New Drug Application, Thermo Fisher Scientific, Generic drug, New Drug Application

Civica Rx (Civica, Inc.) today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.

Key Points: 
  • Civica Rx (Civica, Inc.) today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.
  • By working with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will secure the manufacture of certain essential medications, further mitigating the risk of drug shortages in the future.
  • By partnering with Thermo Fisher, Civica will begin to build its internal pipeline of medications for use in emergency and critical care in the United States.
  • Developing Abbreviated New Drug Applications (ANDAs) for generic drugs and working with contract manufacturing organizations like Thermo Fisher to produce Civica medications.

Patients Are Now Being Treated with a Civica Rx Medication

Retrieved on: 
Wednesday, October 2, 2019
Infectious diseases, Hospitals, Philanthropy, Biotechnology, Pharmaceutical, Health, Other Philanthropy, Chemistry, Civica, Physical sciences, Vancomycin, Natural sciences, Civica Rx, Vancomycin Hydrochloride for Injection, USP

Civica Rx (Civica, Inc.), the collaboration between three philanthropies and now 40 Health Systems representing over 1000 hospitals in 46 states, announced today that patients at Riverton Hospital in Utah are the first to receive a Civica medication, Vancomycin Hydrochloride for Injection, USP.

Key Points: 
  • Civica Rx (Civica, Inc.), the collaboration between three philanthropies and now 40 Health Systems representing over 1000 hospitals in 46 states, announced today that patients at Riverton Hospital in Utah are the first to receive a Civica medication, Vancomycin Hydrochloride for Injection, USP.
  • This is the first time a patient has been treated with a Civica Rx medication since the company was founded in September 2018.
  • This first delivery demonstrates the Civica model in action and is a dream come true, said Martin VanTrieste, President and CEO of Civica Rx.
  • We thank leading health systems across the country who founded or have since become members of Civica for their ongoing commitment and collaboration.

Health Data Curation Company Verinovum Appoints Shawn Frazier as Senior Vice President of Sales

Retrieved on: 
Tuesday, October 1, 2019
Frazier, Civica

TULSA, Okla., Oct. 1, 2019 /PRNewswire-PRWeb/ -- Verinovum , a health data curation company, announced today the appointment of Shawn Frazier, a technology sales professional with more than 30 years' experience, as the company's new Senior Vice President of Sales.

Key Points: 
  • TULSA, Okla., Oct. 1, 2019 /PRNewswire-PRWeb/ -- Verinovum , a health data curation company, announced today the appointment of Shawn Frazier, a technology sales professional with more than 30 years' experience, as the company's new Senior Vice President of Sales.
  • "Shawn is an outstanding addition to our Verinovum team, as he brings a deep blend of industry expertise and technical knowledge," said Mark McCurry, CEO of Verinovum.
  • Prior to joining Verinovum, Frazier spent nearly three years at Master Data Management company VisionWare, which was acquired by Civica during his tenure.
  • Frazier was VP of Sales for US Healthcare and State/Local Government and led the company to its best sales year in the US.